Kezar Life Sciences, Inc. (KZR) Current Deferred Revenue (2018)

Kezar Life Sciences (KZR) posted Current Deferred Revenue of $354000.0 for Q4 2018, up 3.21% sequentially from $343000.0 in Q3 2018.

Kezar Life Sciences, Inc. (KZR) Current Deferred Revenue (2018) Analysis & Trends

Kezar Life Sciences has reported Current Deferred Revenue for 1 years, with the latest figure at $354000.0 in Q4 2018.

Quarterly Current Deferred Revenue changed N/A year-over-year to $354000.0 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $354000.0 (changed N/A YoY) and the FY2018 annual result came in at $354000.0, changed N/A from the prior year.
Current Deferred Revenue grew to $354000.0 in Q4 2018 per KZR's latest filing, from $343000.0 in the prior quarter.
Over five years, Current Deferred Revenue peaked at $354000.0 in Q4 2018 and troughed at $332000.0 in Q2 2018.

Download Data